Novonesis A/S (NVZMY)
OTCMKTS · Delayed Price · Currency is USD
61.12
-1.17 (-1.88%)
Apr 24, 2025, 12:41 PM EDT

Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of 29.18 billion. The enterprise value is 30.90 billion.

Market Cap 29.18B
Enterprise Value 30.90B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date Apr 7, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 346.72M

Valuation Ratios

The trailing PE ratio is 92.17.

PE Ratio 92.17
Forward PE n/a
PS Ratio 7.35
PB Ratio 2.52
P/TBV Ratio 24.47
P/FCF Ratio 41.35
P/OCF Ratio 27.64
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.21, with an EV/FCF ratio of 43.79.

EV / Earnings 97.61
EV / Sales 7.09
EV / EBITDA 25.21
EV / EBIT 32.39
EV / FCF 43.79

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.

Current Ratio 1.73
Quick Ratio 1.05
Debt / Equity 0.16
Debt / EBITDA 1.66
Debt / FCF 2.64
Interest Coverage 10.48

Financial Efficiency

Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.

Return on Equity (ROE) 4.67%
Return on Assets (ROA) 5.54%
Return on Invested Capital (ROIC) 6.61%
Return on Capital Employed (ROCE) 5.97%
Revenue Per Employee 375,056
Profits Per Employee 29,918
Employee Count 10,582
Asset Turnover 0.40
Inventory Turnover 3.05

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +12.99% in the last 52 weeks. The beta is 0.56, so Novonesis's price volatility has been lower than the market average.

Beta (5Y) 0.56
52-Week Price Change +12.99%
50-Day Moving Average 59.18
200-Day Moving Average 61.46
Relative Strength Index (RSI) 58.45
Average Volume (20 Days) 66,724

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novonesis had revenue of 3.97 billion and earned 316.60 million in profits. Earnings per share was 1.14.

Revenue 3.97B
Gross Profit 2.06B
Operating Income 872.66M
Pretax Income 431.83M
Net Income 316.60M
EBITDA 1.12B
EBIT 872.66M
Earnings Per Share (EPS) 1.14
Full Income Statement

Balance Sheet

The company has 289.89 million in cash and 1.86 billion in debt, giving a net cash position of -1.57 billion.

Cash & Cash Equivalents 289.89M
Total Debt 1.86B
Net Cash -1.57B
Net Cash Per Share n/a
Equity (Book Value) 11.57B
Book Value Per Share 41.64
Working Capital 819.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -350.24 million, giving a free cash flow of 705.66 million.

Operating Cash Flow 1.06B
Capital Expenditures -350.24M
Free Cash Flow 705.66M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.

Gross Margin 52.00%
Operating Margin 21.99%
Pretax Margin 10.88%
Profit Margin 7.98%
EBITDA Margin 28.23%
EBIT Margin 21.99%
FCF Margin 17.78%

Dividends & Yields

This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.87%.

Dividend Per Share 0.54
Dividend Yield 0.87%
Dividend Growth (YoY) -4.48%
Years of Dividend Growth n/a
Payout Ratio 81.65%
Buyback Yield -0.64%
Shareholder Yield 0.23%
Earnings Yield 1.08%
FCF Yield 2.42%
Dividend Details

Stock Splits

The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.

Last Split Date Dec 9, 2011
Split Type Forward
Split Ratio 5

Scores

Novonesis has an Altman Z-Score of 5.27.

Altman Z-Score 5.27
Piotroski F-Score n/a